nach oben

Tumor Biology

Erschienen in:

01.12.2014 | Editorial

Letter regarding Meade et al. entitled “Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer”

verfasst von: John D. Fenwick, Zafar Malik, Alan E. Nahum, W. Philip M. Mayles

Erschienen in: Tumor Biology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Meade S, Sanghera P, Glaholm J, Hartley A. Models of acute mucosal tolerance to radiotherapy alone applied by to synchronous chemoradiation schedules in head and neck cancer. Tumor Biol. 2014;35:2017–23.CrossRef

Fenwick JD, Lawrence G, Malik Z, Nahum AE, Mayles WPM. Early mucosal reactions during and following head and neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration. Int J Radiat Oncol Biol Phys. 2008;71:625–34.CrossRef

Fowler JF, Harari PM, Leborgne F, Leborgne J. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol. 2003;69:161–8.CrossRef

Strigari L, Pedicini P, D’Andrea M, Pinnarò P, Marucci L, Giordano C, et al. A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules. Int J Radiat Oncol Biol Phys. 2012;83:e697–702.CrossRef

Ang K, Zhang Q, Wheeler RH, Rosenthal DI, Nguyen-Tan F, Kim H, et al. A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome. J Clin Oncol. 2010;28(15 suppl):5507. ASCO Annual Meeting Proceedings (Post-Meeting Edition).CrossRef

Denham JW, Walker QJ, Lamb DS, Hamilton CS, O’Brien PC, Spry NA, et al. Mucosal regeneration during radiotherapy. Radiother Oncol. 1996;41:109–18.CrossRef

Fletcher GM, MacComb WS, Shalek RJ. Radiation therapy in the management of the oral cavity and oropharynx. Springfield, IL: Charles C Thomas; 1962. p. 51.

Maciejewski B, Skladowski K, Pilecki B, Taylor JMG, Withers RH, Miszczyk L. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report of acute toxicity. Radiother Oncol. 1996;40:137–45.

Bensadoun RJ, Bénézery K, Dassonville O, Magné N, Poissonnet G, Ramaïoli A, et al. French multicentre phase III randomised study testing concurrent twice a day radiotherapy and cisplatin/5-flurouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys. 2006;64:983–94.

10.

Egloff MA, Lee J-W, Langer CJ, Quon H, Vaezi A, Grandis JR, et al. Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303. Clin Cancer Res. 2014;20:5041–51.CrossRef

11.

Bhide SA, Gulliford S, Schick U, Miah A, Zaidi S, Newbold K, et al. Dose–response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiother Oncol. 2012;103:88–91.CrossRef

Titel: Letter regarding Meade et al. entitled “Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer”
verfasst von: John D. Fenwick
Zafar Malik
Alan E. Nahum
W. Philip M. Mayles
Publikationsdatum: 01.12.2014
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 12/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-2874-0

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Letter regarding Meade et al. entitled “Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer”

Excerpt

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2014

A triterpenoid saponin from Adenophora triphylla var. japonica suppresses the growth of human gastric cancer cells via regulation of apoptosis and autophagy

Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case–control study

Efficacy and toxicity of adding cetuximab to chemotherapy in the treatment of metastatic colorectal cancer: a meta-analysis from 12 randomized controlled trials

Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population

The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells

Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie